6712
当前位置: 首页   >  研究方向
研究方向

Dr. Lyu’s Group has been mostly focusing on the method innovations and translational applications of functional metabolomics in the interdisciplinary sciences of life and health. The academic achievements of the candidate can be summarized as the follows: 1) definition and development of novel methods and strategies of functional metabolomics, such as precision-modification metabolomics and spatial temporal operative real metabolomics (STORM). 2) elucidation of the new regulatory-mechanism of siderophore biosynthesis on the virulence formation of pathogenic Escherichia coli; 3) clarification of novel mechanism of biofilm formation in pathogenic Escherichia coli at a functional-metabolism level, conserving novel strategy to tangle all the harmful impact of biofilms by targeting functional metabolites, which are extremely threaten-microorganisms mostly accounted for high-frequency drug resistance, air pollution and food contamination. 4) identification of novel metabolite biomarkers that can facilitate the diagnosis and metastasis monitoring of pancreatic cancer, as well as characterization of novel metabolic targets for disease therapy. Currently, Dr. Lyu’s Group further studies the novel methods of next-generation functional metabolomics (STORM+) aiming at promoting the interdisciplinary applications of life and health sciences by the discovery of poly-functional metabolites. 



Secured Research Grants (PI)

16) Project title: Development of novel strategy for life-omics innovations

Grant Number: SHM-C 2023-12-01C

Funding Body: Shenzhen Science and Technology Commission (Shenzhen, China)

Expected Period: 2024-2026

Total Funding: US $ 500,000.00

Role: Chief Investigator (Dr. Haitao Lu)


15) Project title: Development of novel strategy for life-omics innovations

Grant Number: SKL-GRF 2024-01

Funding Body: State Key Lab of Environmental and Biological Analysis (Hong Kong, China)

Expected Period: 2024-2026

Total Funding: US $ 150,000.00

Role: Chief Investigator (Dr. Haitao Lu)


14) Project title: Development of novel strategy for life-omics innovations

Grant Number: NSLDO-2024-0105

Funding Body: National Laboratory of Diseases and Omics (Shanghai, China)

Expected Period: 2023-2026

Total Funding: US $ 80,000.00

Role: Chief Investigator (Dr. Haitao Lu)


13) Project title: STORM strategy innovated molecular diagnosis and therapeutic targets of

pancreatic cancer

Grant Number: NRCTM(SH)-2021-07

Funding Body: National Research Center for Translational Medicine (Shanghai, China)

Expected Period: 2022-2025

Total Funding: US $ 65,000.00

Role: Chief Investigator (Dr. Haitao Lu)


12) Project title: Investigating the mechanism of siderophore biosynthesis regulating

biofilm formation in Escherichia coli

Grant Number: 21ZR1431600

Funding Body: Shanghai Natural Science Foundation of China

Expected Period: 2021-2024

Total Funding: US $ 40,000.00

Role: Chief Investigator (Dr. Haitao Lu)


11) Project title: STORM strategy innovated therapeutic discovery of pancreatic cancer

Grant Number: 2021-2-4620

Funding Body: Agilent-Applications and Core Technology-University Research Fund

Expected Period: 2021-2022

Total Funding: US $ 35,000.00

Role: Chief Investigator (Dr. Haitao Lu)


10) Project title: Metabolic Phenotyping and Metabolically Modulatory Mechanisms of

Multiple-Organs Metastasis of Pancreatic Cancer

Grant Number: 2017YFC1038

Funding Body: National Key Projects for Research and Innovation of China

Expected Period: 2017-2021

Total Funding: US $ 600,000.00

Role: Chief Investigator (Dr. Haitao Lu)


9) Project title: Pathogenic Escherichia coli guided the discovery and characterization of

novel functional-secondary compounds

Grant Number: 31670031

Funding Body: National Natural Science Foundation of China

Expected Period: 2017-2020

Total Funding: US $ 120,000.00

Role: Chief Investigator (Dr. Haitao Lu)


8) Project title: Development and Applications of Precision-Modification Metabolomics

Grant Number: WF220441502

Funding Body: The Professorship Startup Grant provided by SJTU

Expected Period: 2016-2019

Total Funding: US $ 200,000.00

Role: Chief Investigator (Dr. Haitao Lu)


7) Project title: Discovery and functional characterization of novel siderophores

Grant Number: 106112015CDJZR468808

Funding Body: The Fundamental Research Funds for Then Central Universities Key Grant

Expected Period: 2015-2017

Total Funding: US $ 80,000.00

Role: Chief Investigator (Dr. Haitao Lu)


6) Project title: Metabolomics driven translational research of TCM, Panax Ginseng

against Type 2 Diabetes

Grant Number: CQDXWL-2014-Z002

Funding Body: The Fundamental Research Funds for The Central Universities

Expected Period: 2014-2017

Total Funding: US $ 60,000.00

Role: Chief Investigator (Dr. Haitao Lu)


5) Project title: Metabolomics identifies functional small molecules of Panax Ginseng

against Type 2 Diabetes

Grant Number: CSTC2014JCYIA10109

Funding Body: Natural Science Foundation of Chongqing in China

Expected Period: 2014-2017

Total Funding: US $ 10,000.00

Role: Chief Investigator (Dr. Haitao Lu)


4) Project title: Professional visit as an effort to build collaboration between QUT and

Chongqing University in China

Grant Number: ECARD/VCRF2013-2013

Funding Body: QUT ECARD/VCRF Travel Fellowship

Expected Period: 2013-2014

Total Funding: AU $ 7 K

Role: Chief Investigator (Dr. Haitao Lu)


3) Project title: Identification of key metabolite biomarkers and associated metabolic

pathways for monitoring musculoskeletal injury

Grant Number: 150410-0070/08

Funding Body: QUT Vice Chancellor Research Fellowship

Expected Period: 2013-2014

Total Funding: US $ 250,000.00

Role: Principal Investigator (Dr. Haitao Lu)


2) Project title: Metabolomics identifies bioactive components and associated therapeutic

mechanisms of Pyrrosla lingua (Thunb) at a metabolic level.

Grant Number: 81274175

Funding Body: National Natural Science Foundation of China

Expected Period: 2013-2016

Total Funding: US $ 150,000.00

Role: Chief Investigator (Dr. Haitao Lu)


1) Project title: Development of Integrated Omics Platform and its application to

translational research of the complex diseases

Grant Number: 0236011104401

Funding Body: Chongqing University “Young-100 Talents” Professorship Foundation

Expected Period: 2013-2016

Total Funding: US $ 300,000.00

Role: Principal Investigator (Dr. Haitao Lu)